Haemonetics HAE Cash Flow Statement
| Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | ||
|---|---|---|---|---|---|---|
| —— | $44.74M+19.3% | $38.68M+14.3% | $34.03M-11.3% | $57.98M+185% | ||
| $27.32M-3.2% | $27.39M-5.7% | $28.26M-3.3% | $28.76M-1.3% | $28.21M+2.1% | ||
| $9.13M+31.6% | $7.8M-5.1% | $7.59M+10.7% | $9.31M+22.1% | $6.94M-6.5% | ||
| $77.25M— | $9.3M— | $8.58M+259% | $0— | —— | ||
| $178K-84.2% | $218K+36.3% | $75K-76.0% | $243K-98.3% | $1.13M+208% | ||
| $22.24M+315% | -$11.06M-724% | $7.26M-24.2% | -$3.56M+55.4% | -$10.34M— | ||
| -$8.46M-2,425% | -$13.84M-180% | -$21.76M-302% | -$3.3M-109% | $364K-98.1% | ||
| —— | -$6.7M— | —— | -$47.9M-8.6% | —— | ||
| $5.98M+221% | $2.07M-42.3% | $865K-66.7% | $1.81M-5.8% | $1.86M-68.3% | ||
| $70.94M-39.1% | $93.56M+114% | $111.32M+128% | $17.4M+163% | $116.56M+81.9% | ||
| $17.66M+12.9% | $6.35M-25.7% | $5.02M-46.8% | $3.75M-33.6% | $15.64M+134% | ||
| $60.18M— | $0— | $0-100% | $0-100% | —— | ||
| $0-100% | $10.11M+218% | $7.88M-19.8% | $18.08M+3,243% | $3.6M-33.7% | ||
| $526K-78.5% | $432K+72.1% | $120K-81.6% | $297K-98.5% | $2.45M+345% | ||
| -$86.61M— | -$29.47M-69.6% | -$30.47M-30.4% | -$33M+76.3% | —— | ||
| $100M-33.3% | —— | —— | —— | $150M— | ||
| $0— | $0— | $0— | $0-100% | —— | ||
| -$4.69M-400% | $1.56M+0.1% | $1.56M— | $1.56M0.0% | $1.56M-55.3% | ||
| —— | $1.15M+127% | $63K-74.9% | $462K-51.9% | —— | ||
| $46K— | $160K-64.4% | $14K-68.2% | $4.78M-51.0% | $0— | ||
| -$13K+51.9% | -$14K+90.6% | -$39K-255% | -$36K+41.9% | -$27K+75.0% | ||
| $0— | $0— | $0— | $0-100% | —— | ||
| -$101.5M— | $0-100% | -$76.55M— | -$2.44M-101% | —— | ||
| —— | $810K+113% | —— | $4.18M+389% | —— | ||
| -$117.93M— | $66.94M+210% | $0— | -$13.87M-108% | —— | ||
| $0-100% | $1.32M-60.4% | $2.06M-45.0% | $2.44M-53.5% | $2.64M-21.2% | ||
| $77.25M— | $9.3M— | $8.58M+259% | $0— | —— | ||
| -$469.75K+91.8% | -$469.75K+91.8% | -$469.75K+91.8% | -$469.75K+91.8% | -$5.76M— | ||
| $0— | $0— | $0— | $0-100% | —— | ||
| $5.89M+306% | —— | —— | -$3.35M-3.8% | -$2.86M-206% | ||
| $0-100% | $10.11M+218% | $7.88M-19.8% | $18.08M+3,243% | $3.6M-33.7% | ||
| $526K-78.5% | $432K+72.1% | $120K-81.6% | $297K-98.5% | $2.45M+345% | ||
| -$9.3M-9.9% | -$13.44M-128% | -$17.69M-596% | -$11.46M-172% | -$8.46M-182% | ||
| —— | $0— | $0— | $0-100% | —— | ||
| $0— | $0— | $0— | $0-100% | —— | ||
| $1.79M-3.4% | $2.62M-13.6% | $0— | $3.48M+1.0% | $1.86M+15.3% | ||
| $0-100% | $0-100% | $0-100% | $0-100% | $22.05M— | ||
| $0— | $0— | $0— | $0-100% | —— | ||
| —— | $0— | $0— | $0-100% | —— | ||
| -$13K+51.9% | -$14K+90.6% | -$39K-255% | -$36K+41.9% | -$27K+75.0% | ||
| —— | $0— | $0— | $0-100% | —— | ||
| $75M+61.7% | $75M+61.7% | $75M+61.7% | $75M+61.7% | $46.38M— | ||
| $0— | $0— | $0— | $0-100% | —— | ||
| $0-100% | $0-100% | $0-100% | $0-100% | $62.5M— | ||
| $11.81M— | $11.81M— | $11.81M— | $11.81M— | $0— | ||
| $8.95M— | $8.95M— | $8.95M— | $8.95M— | $0— | ||
| $53.28M-47.2% | $87.22M+148% | $106.31M+170% | $13.64M+141% | $100.91M+75.8% | ||
| $53.28M-47.2% | $87.22M+148% | $106.31M+170% | $13.64M+141% | $100.91M+75.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Haemonetics's cash flow data come from?
- Every line is extracted from Haemonetics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.